- Bedoelde u
- effect
Zoekresultaten - 3131 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
978-92-9498-674-0 Accession Number: NA URL: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-vaccine-effectiveness-hospitalisation.pdf Keywords: COVID-19 Multi-country Vaccine effectiveness Abstract: ...
The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa
the development of an anti-virulence compound that targets the bacterial TCS. Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Publication Type: Peer reviewed scientific article Authors: Elias Vermeiren; Joris Van Loenhout; Léonore Nasiadka; Veerle Stouten; Matthieu Billuart; Izaak Van Evercooren; Lucy Catteau; Pierre Hubin Source: BMC Res Notes, Volume 16, Issue 1 (2023) Keyword ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Humans REGISTRIES Vaccine Efficacy Abstract: BACKGROUND: Within the ECDC- VEBIS project, we prospectively monitored vaccine effectiveness (VE) against COVID-19 hospitalisation and COVID-19-related death ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Publication Type: Peer reviewed scientific article Authors: Meslé, Margaux M I; Sinnathamby, Mary; Mook, Piers; WHO European Region Respiratory Network Group; Pebody, Richard; Lakhani, Anissa; Zambon, Maria; Popovici, Odette; Lazar, Mihaela; Ljubović, Ame ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Efficacy Abstract: IntroductionTwo large multicentre European hospital networks have estimated vaccine effectiveness (VE) against COVID-19 since 2021.AimWe aimed to measure VE against PCR-confirmed ...
Development of novel analytical methods to trace small micro- and nanoplastics in food matrices
strength, or barrier activity against oxygen and carbon dioxide, and the cost-effectiveness. However, apart from macroplastics, we are facing with the serious problem of microplastics (MP s) and nanoplastics ...
Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessmentAbstractIntroductionMethodsResultsConclusions
framework was demonstrated and an analytical pipeline implementing federated causal inference was prototyped using open-source software in preparation for the assessment of real-world effectiveness of ...
Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies
lower socioeconomic status. Existing reviews focus on few, mainly short-term effects of COVID-19 illness and patients with single chronic disease. Information is also largely missing for population ...